Skip to content

Evaluation of Vitamin D in pre-procedural cardiac injury following angioplasty in patients with ischemic heart diseases

Randomized trial of Vitamin D in pre-procedural cardiac injury following angioplasty in patients with ischemic heart diseases

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201402078307N6
Enrollment
100
Registered
2015-01-06
Start date
2014-08-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Effect of Vitamin D in pre-procedural cardiac injury following angioplasty in ischemic heart diseases patients. Ischemic heart diseases

Interventions

Intervention 1: Intervention: In Vitamin D group, all patients will be received totally 300000 unit oral Vitamin D before PCI plus the standard treatment. Intervention 2: Control: In the control gr
Treatment - Drugs
Intervention: In Vitamin D group, all patients will be received totally 300000 unit oral Vitamin D before PCI plus the standard treatment.

Sponsors

Vice chancellor for research, Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Ischemic heart diseases patients; age 18-80; undergoing of angioplasty with stent insertion; filling of consent form. Exclusion Criteria: Elevation of CK-MB and cTnI before PCI; history of CABG during last three months; history of previous MI; renal dysfunction (creatinine above 2.5 mg/dl); unsuccessful PCI; acute MI; cardiogenic shock; dialysis; pregnancy; inability in filling and understanding of the consent form; unconsented patients; patients who want to discontinue the study at any time

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
CK-MB level. Timepoint: 12 hours Before, 8 and 24 hours after angioplasty. Method of measurement: ELISA kits.;CTnI level. Timepoint: Before, 8 and 24 hours after angioplasty. Method of measurement: ELISA.

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026